Ragweed and mugwort are important allergenic weeds belonging to the Asteraceae or Compositae plant family. Pollen of mugwort is one of the main causes of allergic reactions in late summer and autumn in Europe and affects about 10–14% of the patients suffering from pollinosis. Ragweed pollen represents the major source of allergenic protein in the United States, with a prevalence of about 50% in atopic individuals. In Europe, ragweed allergy is now rapidly increasing particularly in certain areas in France, Italy, Austria, Hungary, Croatia, and Bulgaria. Amb a 1 and Art v 1, the major allergens of ragweed and mugwort, respectively, are unrelated proteins. Amb a 1 is an acidic 38-kDa nonglycosylated protein. The natural protein undergoes proteolysis during purification and is cleaved into a 26-kDa alpha chain, which associates noncovalently with the beta chain of 12 kDa. The two-chain form seems to be immunologically indistinguishable from the full-length molecule. Art v 1 is a basic glycoprotein comprising two domains: an N-terminal cysteine-rich, defensin-like domain and a C-terminal proline/hydroxyproline-rich module. The proline/hydroxyproline-rich domain was recently shown to contain two types of glycosylation: (1) a large hydroxyproline-linked arabinogalactan composed of a short β1,6-galactan core substituted by a variable number (5–28) of α-arabinofuranose residues forming branched side chains with 5-, 2,5-, 3,5-, and 2,3,5-substituted arabinoses, and (2) single and adjacent β-arabinofuranoses linked to hydroxyproline. As described for other pollen, ragweed and mugwort pollen also contain the pan-allergen profilin and calcium-binding proteins, which are responsible for extensive cross-reactivity among pollen-sensitized patients.

Keywords:
Ragweed pollen, Mugwort pollen, Allergen, IgE, T cell, Cross-reactivity, Weed pollen allergens
1.
Boulet LP, Turcotte H, Laprise C, Lavertu C, Bedard PM, Lavoie A, Hebert J: Comparative degree and type of sensitization to common indoor and outdoor allergens in subjects with allergic rhinitis and/or asthma. Clin Exp Allergy 1997;27:52–59.
2.
Spieksma FT, Charpin H, Nolard N, Stix E: City spore concentrations in the European Economic Community (EEC). IV. Summer weed pollen (Rumex, Plantago, Chenopodiaceae, Artemisia), 1976 and 1977. Clin Allergy 1980;10:319–329.
3.
Fernandez C, Martin-Esteban M, Fiandor A, Pascual C, Lopez Serrano C, Martinez Alzamora F, Diaz Pena JM, Ojeda Casas JA: Analysis of cross-reactivity between sunflower pollen and other pollens of the Compositae family. J Allergy Clin Immunol 1993;92:660–667.
4.
Hirschwehr R, Heppner C, Spitzauer S, Sperr WR, Valent P, Berger U, Horak F, Jager S, Kraft D, Valenta R: Identification of common allergenic structures in mugwort and ragweed pollen. J Allergy Clin Immunol 1998;101:196–206.
5.
Park HS, Kim MJ, Moon HB: Antigenic relationship between mugwort and ragweed pollens by crossed immunoelectrophoresis. J Korean Med Sci 1994;9:213–217.
6.
D’Amato G, Spieksma FT, Liccardi G, Jager S, Russo M, Kontou-Fili K, Nikkels H, Wuthrich B, Bonini S: Pollen-related allergy in Europe. Allergy 1998;53:567–578.
7.
Jäger S: Ragweed (Ambrosia) sensitisation rates correlate with the amount of inhaled airborne pollen. A 14-year study in Vienna, Austria. Aerobiologia 2000;16:149–153.
8.
Lomagno R: Diffusione del genere Ambrosia in Piemonte e nota preliminare alla sua rilevanza allergologica nella nostra casistica. Folia Allergol Immunol Clin 1984;31:151–155.
9.
Piazza G, Cassani L, Sesia O, Corti M, Dela Torre F: Ragweed evidence in a North Milan hill area (abstract 197). International Symposium: Pollinosis in the Mediterranean Area, Naples, 1989.
10.
Bottero P, Venegoni E, Riccio G, Vignati G, Brivio M, Novi C, Ortolani C: Pollinosi da Ambrosia artemisiifolia in provincia di Milano. Folia Allergol Immunol Clin 1990;37:99–102.
11.
Jäger S: Allergenic significance of Ambrosia (ragweed); in D’Amato G, Spieksma FT, Bonini S (eds): Allergenic Pollen and Pollinosis in Europe. Oxford, Blackwell Scientific Publications, 1991, pp 125–130.
12.
Asero R, Qualizza R, Schilke ML, Sillano V, Zanoletti T: Studio multicentrico sulla prevalenza delle pollinosi nella città e nella provincia di Milano: 1990–95 (abstract). G Ital Allergol Immunol Clin 1998;8:241.
13.
Corsico R, Falagiani P, Ariano R, Berra D, Biale C, Bonifazi F, Campi P, Feliziani V, Frenguelli G, Galimberti M, Gallesio MT, Liccardi G, Loreti A, Marcer G, Marcucci F, Meriggi A, Minelli M, Nardelli R, Nardi G, Negrini CA, Papa G, Piu G, Pozzan M, D’Ambrosio FP, Riva G: An epidemiological survey on the allergological importance of some emerging pollens in Italy. J Investig Allergol Clin Immunol 2000;10:155–161.
14.
Zanon P, Chiodini E, Berra D: Allergy to ragweed in northern Italy and prevention strategies. Monaldi Arch Chest Dis 2002;57:144–146.
15.
Asero R: Birch and ragweed pollinosis north of Milan: a model to investigate the effects of exposure to ‘new’ airborne allergens. Allergy 2002;57:1063–1066.
16.
Asero R: Analysis of new respiratory allergies in patients monosensitized to airborne allergens in the area north of Milan. J Investig Allergol Clin Immunol 2004;14:208–213.
17.
Asero R: Injection immunotherapy with different airborne allergens did not prevent de novo sensitization to ragweed and birch pollen north of Milan. Int Arch Allergy Immunol 2004;133:49–54.
18.
Asero R: Efficacy of injection immunotherapy with ragweed and birch pollen in elderly patients. Int Arch Allergy Immunol 2004;135:332–335.
19.
Rafnar T, Griffith IJ, Kuo MC, Bond JF, Rogers BL, Klapper DG: Cloning of Amb a I (antigen E), the major allergen family of short ragweed pollen. J Biol Chem 1991;266:1229–1236.
20.
Griffith IJ, Pollock J, Klapper DG, Rogers BL, Nault AK: Sequence polymorphism of Amb a I and Amb a II, the major allergens in Ambrosia artemisiifolia (short ragweed). Int Arch Allergy Appl Immunol 1991;96:296–304.
21.
King TP: Chemical and biological properties of some atopic allergens. Adv Immunol 1976;23:77–105.
22.
Tighe H, Takabayashi K, Schwartz D, Van Nest G, Tuck S, Eiden JJ, Kagey-Sobotka A, Creticos PS, Lichtenstein LM, Spiegelberg HL, Raz E: Conjugation of immunostimulatory DNA to the short ragweed allergen amb a 1 enhances its immunogenicity and reduces its allergenicity. J Allergy Clin Immunol 2000;106:124–134.
23.
Marshall JD, Abtahi S, Eiden JJ, Tuck S, Milley R, Haycock F, Reid MJ, Kagey-Sobotka A, Creticos PS, Lichtenstein LM, Van Nest G: Immunostimulatory sequence DNA linked to the Amb a 1 allergen promotes T(H)1 cytokine expression while downregulating T(H)2 cytokine expression in PBMCs from human patients with ragweed allergy. J Allergy Clin Immunol 2001;108:191–197.
24.
Klapper DG, Goodfriend L, Capra JD: Amino acid sequence of ragweed allergen Ra3. Biochemistry 1980;19:5729–5734.
25.
Adolphson C, Goodfriend L, Gleich GJ: Reactivity of ragweed allergens with IgE antibodies. Analyses by leukocyte histamine release and the radioallergosorbent test and determination of cross-reactivity. J Allergy Clin Immunol 1978;62:197–210.
26.
Roebber M, Marsh DG: Isolation and characterization of allergen Amb a VII from short ragweed pollen (abstract). J Allergy Clin Immunol 1991;87:324.
27.
Roebber M, Klapper DG, Marsh DG: Two isoallergens of short ragweed component Ra5. J Immunol 1982;129:120–125.
28.
Ghosh B, Perry MP, Rafnar T, Marsh DG: Cloning and expression of immunologically active recombinant Amb a V allergen of short ragweed (Ambrosia artemisiifolia) pollen. J Immunol 1993;150:5391–5399.
29.
Metzler WJ, Valentine K, Roebber M, Marsh DG, Mueller L: Proton resonance assignments and three-dimensional solution structure of the ragweed allergen Amb a V by nuclear magnetic resonance spectroscopy. Biochemistry 1992;31:8697–8705.
30.
Goodfriend L, Choudhury AM, Klapper DG, Coulter KM, Dorval G, Del Carpio J, Osterland CK: Ra5G, a homologue of Ra5 in giant ragweed pollen: isolation, HLA-DR-associated activity and amino acid sequence. Mol Immunol 1985;22:899–906.
31.
Rafnar T, Ghosh B, Metzler WJ, Huang SK, Perry MP, Mueller L, Marsh DG: Expression and analysis of recombinant Amb a V and Amb t V allergens. Comparison with native proteins by immunological assays and NMR spectroscopy. J Biol Chem 1992;267:21119–21123.
32.
Hiller KM, Lubahn BC, Klapper DG: Cloning and expression of ragweed allergen Amb a 6. Scand J Immunol 1998;48:26–36.
33.
Lubahn B, Klapper DG: Cloning and characterization of ragweed allergen Amb a VI (abstract). J Allergy Clin Immunol 1993;91:338.
34.
Roebber M, Hussain R, Klapper DG, Marsh DG: Isolation and properties of a new short ragweed pollen allergen, Ra6. J Immunol 1983;131:706–711.
35.
Marsh DG, Freidhoff LR, Ehrlich-Kautzky E, Bias WB, Roebber M: Immune responsiveness to Ambrosia artemisiifolia (short ragweed) pollen allergen Amb a VI (Ra6) is associated with HLA-DR5 in allergic humans. Immunogenetics 1987;26:230–236.
36.
Himly M, Jahn-Schmid B, Dedic A, Kelemen P, Wopfner N, Altmann F, van Ree R, Briza P, Richter K, Ebner C, Ferreira F: Art v 1, the major allergen of mugwort pollen, is a modular glycoprotein with a defensin-like and a hydroxyproline-rich domain. FASEB J 2003;17:106–108.
37.
Leonard R, Petersen BO, Himly M, Kaar W, Wopfner N, Kolarich D, van Ree R, Ebner C, Duus JO, Ferreira F, Altmann F: Two novel types of O-glycans on the mugwort pollen allergen Art v 1 and their role in antibody binding. J Biol Chem 2005;280:7932–7940.
38.
Schmid-Grendelmeier P, Holzmann D, Himly M, Weichel M, Tresch S, Ruckert B, Menz G, Ferreira F, Blaser K, Wuthrich B, Crameri R: Native Art v 1 and recombinant Art v 1 are able to induce humoral and T cell-mediated in vitro and in vivo responses in mugwort allergy. J Allergy Clin Immunol 2003;111:1328–1336.
39.
Hartl A, Kiesslich J, Weiss R, Bernhaupt A, Mostbock S, Scheiblhofer S, Ebner C, Ferreira F, Thalhamer J: Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen. J Allergy Clin Immunol 1999;103:107–113.
40.
Bauer R, Himly M, Dedic A, Ferreira F, Thalhamer J, Hartl A: Optimization of codon usage is required for effective genetic immunization against Art v 1, the major allergen of mugwort pollen. Allergy 2003;58:1003–1010.
41.
Nilsen BM, Paulsen BS: Isolation and characterization of a glycoprotein allergen, Art v II, from pollen of mugwort (Artemisia vulgaris L.). Mol Immunol 1990;27:1047–1056.
42.
Nilsen BM, Sletten K, Paulsen BS, O’Neill M, van Halbeek H: Structural analysis of the glycoprotein allergen Art v II from the pollen of mugwort (Artemisia vulgaris L.). J Biol Chem 1991;266:2660–2668.
43.
Diaz-Perales A, Lombardero M, Sanchez-Monge R, Garcia-Selles FJ, Pernas M, Fernandez-Rivas M, Barber D, Salcedo G: Lipid-transfer proteins as potential plant panallergens: cross-reactivity among proteins of Artemisia pollen, Castanea nut and Rosaceae fruits, with different IgE-binding capacities. Clin Exp Allergy 2000;30:1403–1410.
44.
Wopfner N, Willeroider M, Hebenstreit D, van Ree R, Aalbers M, Briza P, Thalhamer J, Ebner C, Richter K, Ferreira F: Molecular and immunological characterization of profilin from mugwort pollen. Biol Chem 2002;383:1779–1789.
45.
Stumvoll S, Westritschnig K, Lidholm J, Spitzauer S, Colombo P, Duro G, Kraft D, Geraci D, Valenta R: Identification of cross-reactive and genuine Parietaria judaica pollen allergens. J Allergy Clin Immunol 2003;111:974–979.
46.
Ortolani C, Ispano M, Pastorello E, Bigi A, Ansaloni R: The oral allergy syndrome. Ann Allergy 1988;61:47–52.
47.
Ortolani C, Pastorello EA, Farioli L, Ispano M, Pravettoni V, Berti C, Incorvaia C, Zanussi C: IgE-mediated allergy from vegetable allergens. Ann Allergy 1993;71:470–476.
48.
Gluck U: Pollinosis and oral allergy syndrome. HNO 1990;38:188–190.
49.
Valenta R, Kraft D: Type 1 allergic reactions to plant-derived food: a consequence of primary sensitization to pollen allergens. J Allergy Clin Immunol 1996;97:893–895.
50.
Asero R: Fennel, cucumber, and melon allergy successfully treated with pollen-specific injection immunotherapy. Ann Allergy Asthma Immunol 2000;84:460–462.
51.
Sloane D, Sheffer A: Oral allergy syndrome. Allergy Asthma Proc 2001;22:321–325.
52.
Yagami T: Allergies to cross-reactive plant proteins. Latex-fruit syndrome is comparable with pollen-food allergy syndrome. Int Arch Allergy Immunol 2002;128:271–279.
53.
Ferreira F, Hawranek T, Gruber P, Wopfner N, Mari A: Allergic cross-reactivity: from gene to the clinic. Allergy 2004;59:243–267.
54.
Gadermaier G, Dedic A, Obermeyer G, Frank S, Himly M, Ferreira F: Biology of weed pollen allergens. Curr Allergy Asthma Rep 2004;4:391–400.
55.
Rogers BL, Morgenstern JP, Griffith IJ, Yu XB, Counsell CM, Brauer AW, King TP, Garman RD, Kuo MC: Complete sequence of the allergen Amb alpha II. Recombinant expression and reactivity with T cells from ragweed allergic patients. J Immunol 1991;147:2547–2552.
56.
Roebber M, Klapper DG, Goodfriend L, Bias WB, Hsu SH, Marsh DG: Immunochemical and genetic studies of Amb.t. V (Ra5G), an Ra5 homologue from giant ragweed pollen. J Immunol 1985;134:3062–3069.
57.
Ghosh B, Rafnar T, Perry MP, Bassolino-Klimas D, Metzler WJ, Klapper DG, Marsh DG: Immunologic and molecular characterization of Amb p V allergens from Ambrosia psilostachya (western ragweed) pollen. J Immunol 1994;152:2882–2889.
58.
Rafnar T, Brummet ME, Bassolino-Klimas D, Metzler WJ, Marsh DG: Analysis of the three-dimensional antigenic structure of giant ragweed allergen, Amb t 5. Mol Immunol 1998;35:459–467.
59.
Niederberger V, Hayek B, Vrtala S, Laffer S, Twardosz A, Vangelista L, Sperr WR, Valent P, Rumpold H, Kraft D, Ehrenberger K, Valenta R, Spitzauer S: Calcium-dependent immunoglobulin E recognition of the apo- and calcium-bound form of a cross-reactive two EF-hand timothy grass pollen allergen, Phl p 7. FASEB J 1999;13:843–856.
60.
Romagnani S: The role of lymphocytes in allergic disease. J Allergy Clin Immunol 2000;105:399–408.
61.
Bond JF, Garman RD, Keating KM, Briner TJ, Rafnar T, Klapper DG, Rogers BL: Multiple Amb a I allergens demonstrate specific reactivity with IgE and T cells from ragweed-allergic patients. J Immunol 1991;146:3380–3385.
62.
Zhu X, Greenstein JL, Rogers BL, Kuo MC: T cell epitope mapping of ragweed pollen allergen Ambrosia artemisiifolia (Amb a 5) and Ambrosia trifida (Amb t 5) and the role of free sulfhydryl groups in T cell recognition. J Immunol 1995;155:5064–5073.
63.
Huang SK, Yi M, Palmer E, Marsh DG: A dominant T cell receptor beta-chain in response to a short ragweed allergen, Amb a 5. J Immunol 1995;154:6157–6162.
64.
Huang SK, Zwollo P, Marsh DG: Class II major histocompatibility complex restriction of human T cell responses to short ragweed allergen, Amb a V. Eur J Immunol 1991;21:1469–1473.
65.
Ebner C, Szepfalusi Z, Ferreira F, Jilek A, Valenta R, Parronchi P, Maggi E, Romagnani S, Scheiner O, Kraft D: Identification of multiple T cell epitopes on Bet v I, the major birch pollen allergen, using specific T cell clones and overlapping peptides. J Immunol 1993;150:1047–1054.
66.
van Neerven RJ, Ebner C, Yssel H, Kapsenberg ML, Lamb JR: T-cell responses to allergens: epitope-specificity and clinical relevance. Immunol Today 1996;17:526–532.
67.
Jahn-Schmid B, Kelemen P, Himly M, Bohle B, Fischer G, Ferreira F, Ebner C: The T cell response to Art v 1, the major mugwort pollen allergen, is dominated by one epitope. J Immunol 2002;169:6005–6011.
68.
Jahn-Schmid B, Fischer GF, Bohle B, Fae I, Gadermaier G, Dedic A, Ferreira F, Ebner C: Antigen presentation of the immunodominant T-cell epitope of the major mugwort pollen allergen, Art v 1, is associated with the expression of HLA-DRB1*01. J Allergy Clin Immunol 2005;115:399–404.
69.
Young RP, Dekker JW, Wordsworth BP, Schou C, Pile KD, Matthiesen F, Rosenberg WM, Bell JI, Hopkin JM, Cookson WO: HLA-DR and HLA-DP genotypes and immunoglobulin E responses to common major allergens. Clin Exp Allergy 1994;24:431–439.
70.
Faux JA, Moffatt MF, Lalvani A, Dekker J, Warrell DA, Cookson WO: Sensitivity to bee and wasp venoms: association with specific IgE responses to the bee and wasp venom and HLA DRB1 and DPB1. Clin Exp Allergy 1997;27:578–583.
71.
Haselden BM, Kay AB, Larche M: Peptide-mediated immune responses in specific immunotherapy. Int Arch Allergy Immunol 2000;122:229–237.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.